{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"description":"Safety of plerixafor as measured by Grade III/IV Toxicity","groups":[{"description":"Patients who were unable to mobilize a minimum number of cells (CD34+ cell count \\<20 cells/ul)following 5 days of G-CSF mobilization.","id":"OG000","title":"G-CSF Plus Plerixafor"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"6 months post transplant or until relapse","title":"Number of Participants Experiencing a Grade III/IV Toxicity","type":"SECONDARY","unitOfMeasure":"participants"}